环丙基(4-氟苄基)胺 | 625437-46-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 环丙基(4-氟苄基)胺
• 英文名称: N-[(4-fluorophenyl)methyl]cyclopropanamine
• 英文别名: N-(4-fluorobenzyl) cyclopropanamine；4-fluoro-N-cyclopropylbenzylamine；cyclopropyl-(4-fluorobenzyl)amine；N-(4-Fluorobenzyl)cyclopropanamine
• CAS: 625437-46-9
• 化学式: C₁₀H₁₂FN
• mdl: MFCD07330007
• 分子量: 165.21
• InChiKey: YKNFXOCMGURJMK-UHFFFAOYSA-N

物化性质

• 熔点：
  186℃
• 沸点：
  236℃
• 密度：
  1.09
• 闪点：
  96℃

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  8
• 海关编码：
  2921499090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: N-(4-Fluorobenzyl)cyclopropanamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H314: Causes severe skin burns and eye damage
H318: Causes serious eye damage
P260: Do not breathe dust/fume/gas/mist/vapours/spray
P303+P361+P353: IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: N-(4-Fluorobenzyl)cyclopropanamine
CAS number: 625437-46-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H12FN
Molecular weight: 165.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2735 Class: 8 Packing group: III
Proper shipping name: AMINES, LIQUID, CORROSIVE, N.O.S. OR POLYAMINES, LIQUID, CORROSIVE, N.O.S.
(N-(4-Fluorobenzyl)cyclopropanamine)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  环丙基(4-氟苄基)胺 在 sodium tungstate 、 双氧水 作用下， 以 甲醇 、 水 为溶剂， 生成 N-cyclopropyl-1-(4-fluorophenyl)methanimine oxide
  参考文献：
  名称：

  Synthesis of C-Aryl-N-cyclopropylnitrones

  摘要：

  Synthesis of C-aryl-N-cyclopropylnitrones is described. Preparations were performed either by condensation of the appropriate aldehyde with N-cyclopropyl-hydroxylamine, or oxidation of N-substituted N-cyclopropylamines with sodium tungstate/hydrogen peroxide.

  DOI：

  10.1081/scc-120024001
• 作为产物：
  描述：

  (E)-N-环丙基-1-(4-氟苯基)甲亚胺 在 sodium tetrahydroborate 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 22.0h， 生成 环丙基(4-氟苄基)胺
  参考文献：
  名称：

  涉及功能化二硫代氨基甲酸酯和三苯基膦的 Ni(II) 配合物的合成和光谱表征：（N-环丙基-N-（4-氟苄基）二硫代氨基甲酸-S，S'）（硫氰酸根合-N）（三苯基膦）镍（II）中的拮抗作用

  摘要：

  摘要 十二种新的镍 (II) 配合物，即 [Ni(S2CNRR')2](1-6) 和 [Ni(S2CNRR')(NCS)(PPh3)](7-12) [其中 R = 环丙基 (cPr); R' = 2HO–C6H4–CH2– (1,7)、3HO–C6H4–CH2– (2,8)、4HO–C6H4–CH2– (3,9)、4CH3O–C6H4–CH2– (4,10) , 4F–C6H4–CH2– (5,11), 4Cl–C6H4–CH2– (6,12)] 已通过元素分析、IR、UV–Vis 和 NMR（1H 和 13C）光谱制备和表征。对（N-环丙基-N-（4-氟苄基）二硫代氨基甲酸根-S，S'）（硫氰酸根合-N）-（三苯基膦）镍（II）进行单晶X射线结构分析。与均配配合物 1-6 相比，vC-N 硫脲的波数增加和杂配配合物 7-12 的化学位移值降低是由于电子密度从二硫代氨基甲酸酯部分向金属中心的中间漂移，增加碳氮双键特性。C-N

  DOI：

  10.1016/j.molstruc.2015.08.053

文献信息

• 三氮唑化合物及其在农业中的应用
  申请人：东莞市东阳光农药研发有限公司

  公开号：CN108689951B

  公开（公告）日：2020-05-19

  本发明提供一种三氮唑化合物及其在农业中的应用；具体地，本发明提供式(A)所示的化合物及其制备方法；含有这些化合物的组合物和制剂及其作为杀菌剂的用途；其中R1、R2、R3、w、R4、R5、R6、R7、R8、R9、Ra、Rb和x具有如本发明所给出的含义。
• Cinnamide compound
  申请人：Kimura Teiji

  公开号：US20060004013A1

  公开（公告）日：2006-01-05

  The present invention relates to a compound represented by Formula (I): (wherein Ar 1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar 2 represents a pyridinyl group, a pyrimidinyl group, or a phenyl group which may be substituted with 1 to 3 substituents; X 1 represents (1) —C≡C— or (2) a double bond etc. which may be substituted; R 1 and R 2 represent, for example, a C1-6 alkyl group or C3-8 cycloalkyl group which may be substituted) or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents. The object of the present invention is to find a therapeutic or preventive agent for diseases caused by Aβ. According to the present invention, a therapeutic or preventive agents for diseases caused by Aβ can be provided.

  本发明涉及一种由式（I）表示的化合物：（其中Ar1代表可以被1到3个取代基取代的咪唑基团；Ar2代表可以被1到3个取代基取代的吡啶基团、嘧啶基团或苯基；X1代表（1）-C≡C-或（2）可以被取代的双键等；R1和R2代表，例如，可以被取代的C1-6烷基或C3-8环烷基等）或其药理学上可接受的盐，并且用作药物剂。本发明的目的是寻找一种治疗或预防由Aβ引起的疾病的药剂。根据本发明，可以提供治疗或预防由Aβ引起的疾病的药剂。
• 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension,cardiovascular or renal diseases
  申请人：Bezencon Olivier

  公开号：US20050176700A1

  公开（公告）日：2005-08-11

  The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.

  本发明涉及式(I)的新型3,9-二氮杂双环[3.3.1]壬烯衍生物及其相关化合物，以及它们作为药物组分在制备药物组合物中的应用。本发明还涉及相关方面，包括制备这些化合物的过程、含有其中一个或多个这些化合物的药物组合物，尤其是它们作为肾素抑制剂的应用。
• Cinnamide Compound
  申请人：Kimura Teiji

  公开号：US20080070902A1

  公开（公告）日：2008-03-20

  The present invention relates to a compound represented by Formula (I): (wherein Ar 1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar 2 represents a pyridinyl group, a pyrimidinyl group, or a phenyl group which may be substituted with 1 to 3 substituents; X 1 represents (1) —C≡C— or (2) a double bond etc. which may be substituted; R 1 and R 2 represent, for example, a C1-6 alkyl group or C3-8 cycloalkyl group which may be substituted) or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents.

  本发明涉及一种由公式(I)表示的化合物：（其中Ar1代表一个咪唑基，可以用1到3个取代基取代；Ar2代表一个吡啶基，嘧啶基或苯基，可以用1到3个取代基取代；X1代表（1）-C≡C-或（2）一个双键等，可以用取代基取代；R1和R2代表例如C1-6烷基或C3-8环烷基，可以用取代基取代）或其药学上可接受的盐，并用作制药剂。
• CINNAMIDE COMPOUND
  申请人：KIMURA Teiji

  公开号：US20090281310A1

  公开（公告）日：2009-11-12

  The present invention relates to a process for preparing a compound of formula (6a): wherein Ar 1 represents an imidazolyl group which may be substituted with 1 to 3 substituents shown below; Ar 2 represents a pyridinyl group, a pyrimidinyl group or a phenyl group which may be substituted with 1 to 3 substituents; and R 11 represents a group selected from certain substituents.

  本发明涉及一种制备式（6a）化合物的方法，其中Ar1代表一种咪唑基团，该基团可能被下列1至3个取代基取代；Ar2代表一种吡啶基团、嘧啶基团或苯基团，该基团可能被下列1至3个取代基取代；R11代表从某些取代基中选择的一种基团。